Preeclampsia and pregnancies with small-for-gestational age neonates have different profiles of complement split products
- 20 October 2009
- journal article
- research article
- Published by Taylor & Francis Ltd in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 23 (7), 646-657
- https://doi.org/10.3109/14767050903301009
Abstract
Objective. The activation of the complement system results in the generation of split products with pro-inflammatory properties. The objective of this study was to determine whether preeclampsia and small-for-gestational age (SGA) are associated with changes in the maternal plasma concentrations of anaphylatoxins C3a, C4a and C5a. Methods. A cross-sectional study was conducted in the following groups: (a) normal pregnant women (n = 134); (b) women who delivered an SGA neonate (n = 53); (c) preeclampsia with (n = 52) and without SGA (n = 54). Maternal plasma anaphylatoxin concentrations were determined by enzyme-linked immunoassay. Results. (1) Women with preeclampsia with or without SGA had a significantly higher median plasma C5a concentration than that of normal pregnant women and those with SGA alone (all P < 0.01); (2) women with SGA alone did not have an increase in plasma C5a concentration; (3) in contrast, the median maternal plasma concentration of C4a was lower in women with preeclampsia and SGA than that of those with a normal pregnancy (P = 0.001); (4) no changes in C3a were observed among the study groups. Conclusion. Preeclampsia is associated with increased plasma concentration of C5a, regardless of the presence or absence of an SGA fetus. In contrast, there was no difference in the plasma C3a, C4a and C5a concentration in patients with SGA.Keywords
This publication has 153 references indexed in Scilit:
- Alternative complement pathway activation fragment Bb in early pregnancy as a predictor of preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2008
- Tissue factor and its natural inhibitor in pre-eclampsia and SGAThe Journal of Maternal-Fetal & Neonatal Medicine, 2008
- A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonateThe Journal of Maternal-Fetal & Neonatal Medicine, 2008
- Total and free tissue factor pathway inhibitor in pregnancy hypertensionInternational Journal of Gynecology & Obstetrics, 2006
- Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia developAmerican Journal of Obstetrics and Gynecology, 2004
- Intrauterine growth restriction increases morbidity and mortality among premature neonatesAmerican Journal of Obstetrics and Gynecology, 2004
- The role of uterine artery Doppler in predicting adverse pregnancy outcomeBest Practice & Research Clinical Obstetrics & Gynaecology, 2004
- Pathophysiology of Preeclampsia: Linking Placental Ischemia/Hypoxia with Microvascular DysfunctionMicrocirculation, 2002
- Placental Cytokines and the Pathogenesis of PreeclampsiaAmerican Journal of Reproductive Immunology, 1997
- COMPLEMENT COMPONENTS IN NORMAL PREGNANCYActa Pathologica Microbiologica Scandinavica Series C: Immunology, 1987